Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 23864149)

1.

Stochastic Virtual Population of Subjects with Type 1 Diabetes for the Assessment of Closed Loop Glucose Controllers.

Haidar A, Wilinska M, Graveston J, Hovorka R.

IEEE Trans Biomed Eng. 2013 Jul 11. [Epub ahead of print]

PMID:
23864149
2.

Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies.

Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1109-20.

3.

Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward.

Hovorka R, Nodale M, Haidar A, Wilinska ME.

Diabetes Technol Ther. 2013 Jan;15(1):4-12. doi: 10.1089/dia.2012.0185. Epub 2012 Oct 9.

4.

In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes.

Kovatchev BP, Breton M, Man CD, Cobelli C.

J Diabetes Sci Technol. 2009 Jan;3(1):44-55.

5.

Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results.

Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A.

J Diabetes Sci Technol. 2010 Nov 1;4(6):1374-81.

6.

Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial.

Magni L, Forgione M, Toffanin C, Dalla Man C, Kovatchev B, De Nicolao G, Cobelli C.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1091-8.

7.

Evaluation of glucose controllers in virtual environment: methodology and sample application.

Chassin LJ, Wilinska ME, Hovorka R.

Artif Intell Med. 2004 Nov;32(3):171-81.

PMID:
15531149
8.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.

Bruttomesso D, Farret A, Costa S, Marescotti MC, Vettore M, Avogaro A, Tiengo A, Dalla Man C, Place J, Facchinetti A, Guerra S, Magni L, De Nicolao G, Cobelli C, Renard E, Maran A.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1014-21.

9.

Diabetes technology and treatments in the paediatric age group.

Shalitin S, Peter Chase H.

Int J Clin Pract Suppl. 2011 Feb;(170):76-82. doi: 10.1111/j.1742-1241.2010.02582.x. Review.

PMID:
21323816
10.

Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial.

Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De Palma A, Wilinska ME, Acerini CL, Dunger DB.

Lancet. 2010 Feb 27;375(9716):743-51. doi: 10.1016/S0140-6736(09)61998-X. Epub 2010 Feb 4.

11.

A simulation model of glucose regulation in the critically ill.

Hovorka R, Chassin LJ, Ellmerer M, Plank J, Wilinska ME.

Physiol Meas. 2008 Aug;29(8):959-78. doi: 10.1088/0967-3334/29/8/008. Epub 2008 Jul 18.

PMID:
18641427
12.

In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop.

Dassau E, Palerm CC, Zisser H, Buckingham BA, Jovanovic L, Doyle FJ.

Diabetes Technol Ther. 2009 Mar;11(3):187-94. doi: 10.1089/dia.2008.0055.

PMID:
19191486
13.

Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies.

Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML.

BMJ. 2011 Apr 13;342:d1855. doi: 10.1136/bmj.d1855.

14.

Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial.

Haidar A, Legault L, Dallaire M, Alkhateeb A, Coriati A, Messier V, Cheng P, Millette M, Boulet B, Rabasa-Lhoret R.

CMAJ. 2013 Mar 5;185(4):297-305. doi: 10.1503/cmaj.121265. Epub 2013 Jan 28.

15.

Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.

Ruan Y, Thabit H, Wilinska ME, Hovorka R.

Biomed Eng Online. 2015 Mar 4;14(1):19. doi: 10.1186/s12938-015-0009-5.

16.
17.

A population-based Bayesian approach to the minimal model of glucose and insulin homeostasis.

Andersen KE, HĂžjbjerre M.

Stat Med. 2005 Aug 15;24(15):2381-400.

PMID:
15977291
18.

Probabilistic evolving meal detection and estimation of meal total glucose appearance.

Cameron F, Niemeyer G, Buckingham BA.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1022-30.

19.

Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience.

Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1031-8.

20.

Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes.

Kanderian SS, Weinzimer S, Voskanyan G, Steil GM.

J Diabetes Sci Technol. 2009 Sep 1;3(5):1047-57.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk